Jung-hwan J. Yoon-Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
When viruses recede and alcohol advances: demographic momentum and policy gaps in alcohol-associated liver cancer.
Journal: Hepatology international
Published: January 16, 2026
Correspondence to editorial 2 on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis".
Journal: Clinical and molecular hepatology
Published: January 09, 2026
Correspondence to editorial 1 on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis".
Journal: Clinical and molecular hepatology
Published: January 09, 2026
Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
Journal: Diagnostic and interventional imaging
Published: July 16, 2025
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
Journal: Journal of hepatology
Published: February 26, 2023
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
Journal: Journal of Korean medical science
Published: October 19, 2022
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis.
Journal: BMC gastroenterology
Published: September 15, 2021
A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
Journal: Digestive diseases and sciences
Published: October 10, 2020
Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study.
Journal: Cancers
Published: September 17, 2019
Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: February 14, 2019
Hepatitis B virus X protein induces size-selective membrane permeabilization through interaction with cardiolipin.
Journal: Biochimica et biophysica acta. Biomembranes
Published: July 03, 2018
Last Updated: 09/26/2026